
    
      This is a double blind, randomized, active controlled, phase 3 study. Subjects will be
      randomly assigned to one of the two treatment groups (CJ-12420 50mg, lansoprazole 30mg). All
      subjects will be asked to take 5 tablets include clarithromycin, amoxicillin twice a day for
      7 days.

      After the treatment, UBT test will be conducted to confirm the Helicobacter pylori
      eradication.
    
  